Want to see JP:6381 full AI Analyst Report?
Top Page
ANEST IWATA Corp.
(6381)
Select Model
Select Model
Rating:83Outperform
Price Target:
¥1,948.00
▲(19.22% Upside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by strong financial quality (notably the very low leverage and solid profitability) and an attractive valuation (low P/E with a high dividend yield). Technicals are supportive with the stock above major moving averages, but slightly extended momentum and historically uneven cash conversion temper the overall rating.
Positive Factors
Conservative Balance Sheet
Exceptionally low leverage and steadily growing equity give durable financial flexibility. This enables funding of capex, R&D, dividends or M&A without reliance on costly debt, improving resilience in downturns and preserving long-term strategic optionality.
Negative Factors
Margin Volatility
Operating margins have swung across periods, reducing earnings predictability. Persistent margin volatility complicates capital allocation and strategic planning and may signal exposure to commodity/input cost swings, product-mix shifts or operating leverage limits.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Exceptionally low leverage and steadily growing equity give durable financial flexibility. This enables funding of capex, R&D, dividends or M&A without reliance on costly debt, improving resilience in downturns and preserving long-term strategic optionality.
Read all positive factors
ANEST IWATA Corp. (6381) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥69.17B
Dividend Yield3.95%
Average Volume (3M)80.39K
Price to Earnings (P/E)12.9
Beta (1Y)0.77
Revenue Growth2.75%
EPS Growth25.74%
CountryJP
Employees1,865
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)136.03
Shares Outstanding41,745,502
10 Day Avg. Volume57,960
30 Day Avg. Volume80,393
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)1.23
Price to Sales (P/S)1.12
P/FCF Ratio12.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)119.3
Revenue Forecast (FY)¥56.30B
ANEST IWATA Corp. Business Overview & Revenue Model
Company Description
Established in Yokohama, Japan, in 1926, ANEST IWATA Corporation is a global enterprise specializing in air energy and coating technologies. Its air energy division provides a broad range of products, including air compressors and nitrogen gas gen...
How the Company Makes Money
ANEST IWATA primarily makes money by manufacturing and selling industrial equipment used in production and finishing processes. Key revenue streams include: (1) Coating/painting equipment sales—revenue from spray guns, coating/painting systems, an...
ANEST IWATA Corp. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
90
Very Positive
Cash Flow
71
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 55.91B | 54.41B | 53.42B | 48.52B | 42.34B |
| Gross Profit | 26.14B | 26.08B | 24.48B | 21.34B | 18.23B |
| EBITDA | 8.05B | 8.39B | 8.43B | 7.91B | 6.54B |
| Net Income | 5.36B | 4.28B | 4.93B | 4.38B | 3.54B |
Balance Sheet | |||||
| Total Assets | 74.64B | 69.96B | 66.14B | 60.14B | 55.82B |
| Cash, Cash Equivalents and Short-Term Investments | 20.75B | 21.34B | 16.93B | 14.51B | 14.32B |
| Total Debt | 2.74B | 2.87B | 3.07B | 2.67B | 2.42B |
| Total Liabilities | 17.09B | 16.40B | 16.07B | 14.88B | 15.61B |
| Stockholders Equity | 50.75B | 46.85B | 44.16B | 40.03B | 35.62B |
Cash Flow | |||||
| Free Cash Flow | 4.94B | 7.08B | 4.95B | 2.48B | 3.02B |
| Operating Cash Flow | 8.14B | 9.75B | 6.77B | 4.33B | 3.89B |
| Investing Cash Flow | -4.33B | -3.25B | -1.26B | -3.32B | -1.08B |
| Financing Cash Flow | -3.86B | -3.93B | -3.58B | -2.36B | -2.10B |
ANEST IWATA Corp. Technical Analysis
Positive
1634.00
Price Trends
1652.18
Positive
1643.86
Positive
1598.04
Positive
Market Momentum
30.26
Negative
66.61
Neutral
71.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6381, the sentiment is Positive. The current price of 1634 is below the 20-day moving average (MA) of 1692.20, below the 50-day MA of 1652.18, and above the 200-day MA of 1598.04, indicating a bullish trend. The MACD of 30.26 indicates Negative momentum. The RSI at 66.61 is Neutral, neither overbought nor oversold. The STOCH value of 71.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6381.
ANEST IWATA Corp. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥69.17B | 12.87 | ― | 3.95% | 2.75% | 25.74% | |
80 Outperform | ¥70.03B | 13.00 | ― | 2.63% | 2.11% | 0.91% | |
78 Outperform | ¥93.10B | 20.47 | ― | 2.79% | 4.22% | 7.91% | |
74 Outperform | ¥45.24B | 12.03 | ― | 3.95% | -4.76% | 20.35% | |
70 Outperform | ¥76.01B | 12.93 | ― | 3.09% | 7.43% | 47.87% | |
65 Neutral | ¥227.72B | 16.85 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
JP:6381
ANEST IWATA Corp.
1,751.00
368.48
26.65%
JP:6376
Nikkiso Co., Ltd.
3,715.00
2,447.38
193.07%
JP:6237
Iwaki Co. Ltd.
4,335.00
1,875.53
76.26%
JP:6333
Teikoku Electric Manufacturing Co., Ltd.
3,145.00
138.39
4.60%
JP:6363
Torishima Pump Mfg.Co., Ltd.
2,920.00
892.76
44.04%
JP:6517
Denyo Co., Ltd.
3,575.00
781.18
27.96%
ANEST IWATA Corp. Corporate Events
ANEST IWATA Sets Long-Term Strategy to Realize Vision 2035
May 12, 2026
ANEST IWATA Corporation has unveiled a long-term growth strategy as a master plan to achieve its Vision 2035, signaling a structured roadmap for its future development. The plan outlines how the group intends to steer its operations and investment...
ANEST IWATA Launches Share Buyback to Boost Capital Efficiency
May 12, 2026
ANEST IWATA Corporation has approved a new share repurchase program as part of its broader capital policy and commitment to enhancing shareholder returns. The company aims to use flexible buybacks while preserving a solid financial base to support...
ANEST IWATA to Expand Business Scope with Automotive-Related Services
May 12, 2026
ANEST IWATA Corporation plans to amend its Articles of Incorporation to broaden its stated business purposes, reflecting an expansion and diversification of its business domains across the group. The proposal, approved by the board, will be submit...
ANEST IWATA Doubles Annual Dividend and Adopts DOE-Based Payout Policy
May 12, 2026
ANEST IWATA Corporation’s board has approved a year-end dividend of JPY 46.00 per share for the fiscal year ended March 31, 2026, with a record date of March 31 and an effective payment date of June 29, subject to shareholder approval. This ...
ANEST IWATA lifts sales and net profit, forecasts margin squeeze amid 100th anniversary investments
May 12, 2026
ANEST IWATA reported FY2025 net sales of 55,909 million yen, up 2.8% year on year, with growth driven by strong air compressor demand from European OEMs and higher sales of coating equipment and systems in China, Japan and India. Despite revenue g...
ANEST IWATA Lifts Earnings and Dividends but Flags Profit Dip Ahead
May 12, 2026
ANEST IWATA reported fiscal 2025 consolidated net sales of ¥55.9 billion, up 2.8% year on year, with operating profit slipping 5.8% to ¥5.56 billion but ordinary profit rising 8.1% and profit attributable to owners of parent jumping 25.2...
ANEST IWATA Revamps Board Lineup With New Outside Director, Maintains Leadership Stability
Mar 18, 2026
ANEST IWATA Corporation has announced a slate of director candidates, primarily consisting of reappointments of its existing leadership team, including President and CEO Eisuke Miyoshi, for approval at its 80th Annual General Meeting of Shareholde...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.